Intellia Therapeutics Inc buy Raymond James
Start price
10.11.23
/
50%
€22.91
Target price
10.11.24
€53.33
Performance (%)
-31.17%
End price
11.11.24
€15.77
Summary
This prediction ended on 11.11.24 with a price of €15.77. Massive losses of -31.17% were the result for the BUY prediction by Raymond_James. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -3.048% | -3.048% | -39.066% |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% |
Comments by Raymond_James for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Raymond James from $78.00 to $57.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten